Legal & General Group Plc - GENMARK DIAGNOSTICS INC ownership

GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 87 filers reported holding GENMARK DIAGNOSTICS INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Legal & General Group Plc ownership history of GENMARK DIAGNOSTICS INC
ValueSharesWeighting
Q1 2021$393,000
+82.8%
16,433
+11.3%
0.00%
Q4 2020$215,000
+1.9%
14,760
-0.5%
0.00%
Q3 2020$211,000
-18.8%
14,836
-15.9%
0.00%
Q2 2020$260,000
+271.4%
17,646
+4.7%
0.00%
Q1 2020$70,000
-27.1%
16,860
-15.5%
0.00%
Q4 2019$96,000
-11.1%
19,958
+12.6%
0.00%
Q3 2019$108,000
+22.7%
17,721
+31.4%
0.00%
Q2 2019$88,000
+1.1%
13,487
+10.4%
0.00%
Q1 2019$87,000
+58.2%
12,213
+8.0%
0.00%
Q4 2018$55,000
-1.8%
11,308
+48.6%
0.00%
Q3 2018$56,000
+14.3%
7,6080.0%0.00%
Q2 2018$49,000
-3.9%
7,608
-19.9%
0.00%
Q1 2018$51,000
-7.3%
9,500
-26.7%
0.00%
Q4 2017$55,000
-55.6%
12,9520.0%0.00%
Q3 2017$124,000
-9.5%
12,952
+12.4%
0.00%
Q2 2017$137,000
-5.5%
11,521
+2.1%
0.00%
Q1 2017$145,000
+2.8%
11,281
-1.3%
0.00%
Q4 2016$141,000
+80.8%
11,430
+61.3%
0.00%
Q3 2016$78,000
+13.0%
7,087
-12.8%
0.00%
Q2 2016$69,000
+64.3%
8,1270.0%0.00%
Q1 2016$42,000
-32.3%
8,1270.0%0.00%
Q4 2015$62,0000.0%8,1270.0%0.00%
Q3 2015$62,000
-17.3%
8,1270.0%0.00%
Q2 2015$75,000
-30.6%
8,1270.0%0.00%
Q1 2015$108,000
-4.4%
8,1270.0%0.00%
Q4 2014$113,000
+54.8%
8,1270.0%0.00%
Q3 2014$73,0008,1270.00%
Other shareholders
GENMARK DIAGNOSTICS INC shareholders Q1 2016
NameSharesValueWeighting ↓
Casdin Capital, LLC 3,500,000$25,725,0003.13%
CADIAN CAPITAL MANAGEMENT, LP 3,830,399$28,153,0001.28%
Mesirow Financial Investment Management, Inc. 33,001$243,0001.25%
Bellevue Group AG 1,339,502$9,845,0000.62%
NEEDHAM INVESTMENT MANAGEMENT LLC 260,000$1,912,0000.58%
Lyon Street Capital, LLC 109,850$807,0000.50%
Private Wealth Partners, LLC 300,000$2,205,0000.34%
Penn Capital Management Company, LLC 455,064$3,345,0000.25%
HighTower Advisors, LLC 2,337,132$17,179,0000.12%
Schonfeld Strategic Advisors LLC 376,000$2,763,0000.12%
View complete list of GENMARK DIAGNOSTICS INC shareholders